Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds are described that correspond to general formula (I). Also described, are pharmaceutical compositions that include these compounds and methods of using these compounds and compositions for the treatment of chemokine-mediated diseases.
本文描述了符合通式(I)的二取代
3,4-二氨基-3-环丁烯-1,2-二酮化合物。同时还描述了包含这些化合物的药物组合物以及使用这些化合物和组合物治疗
趋化因子介导疾病的方法。